These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12501793)

  • 1. [Prospects of the use of adaptogenic amino acids in the pathogenetic therapy of a number of pathologic states].
    Pavlov VA; Sabadash EV
    Probl Tuberk; 2002; (11):26-8. PubMed ID: 12501793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects in the search for new biological agents to prevent tuberculosis].
    Kolomiets VM; Evglevskiĭ AA; Kovalenko AM; Timkova EA
    Probl Tuberk; 2002; (10):31-3. PubMed ID: 12593166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of vanadyl sulfate in experimental tuberculosis].
    Bala IuM; Zavrazhnov VI; Kopylova LM
    Farmakol Toksikol; 1971; 34(3):346-8. PubMed ID: 4998682
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphological features of tissue reactions in combined treatment of experimental tuberculosis induced by xenobiotics].
    Pavlov VA; Kazak TI; Kleĭn AV; Nosova NA
    Probl Tuberk; 1995; (6):32-5. PubMed ID: 8524767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
    Basaraba RJ; Izzo AA; Brandt L; Orme IM
    Vaccine; 2006 Jan; 24(3):280-6. PubMed ID: 16153758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant and Antimutagenic Metabolites in Animals with Opposite Sensitivity to Tuberculosis Mycobacteria and Mutagenic Xenobiotics.
    Pavlov VA; Kotomtsev VV; Doronin AI; Sabadash EV
    Bull Exp Biol Med; 2016 Nov; 162(1):63-65. PubMed ID: 27878723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diribiotine aerosols administered to patients with chronic bronchial obstruction. Double-blind study].
    Obrecht U; Scherrer M
    Rev Med Suisse Romande; 1975 May; 95(5):345-59. PubMed ID: 1101345
    [No Abstract]   [Full Text] [Related]  

  • 8. [Purification and application of tuberculosis adjuvants].
    Tanaka A
    Nihon Rinsho; 1974 Jul; 32(7):2518-25. PubMed ID: 4215911
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41.
    Skeiky YA; Alderson MR; Ovendale PJ; Lobet Y; Dalemans W; Orme IM; Reed SG; Campos-Neto A
    Vaccine; 2005 Jun; 23(30):3937-45. PubMed ID: 15917115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of cycloserine inhibition of mycobacteria.
    Hawkins JE; McClean VR
    Am Rev Respir Dis; 1966 Apr; 93(4):594-602. PubMed ID: 4956240
    [No Abstract]   [Full Text] [Related]  

  • 11. [Impact of mycobacteria on nonspecific protective mechanisms associated with exchange of organic sulphur and nitrogen].
    Pavlov VA
    Probl Tuberk; 1997; (3):48-51. PubMed ID: 9265175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Purification of an active adjuvant substance from Mycobacterium tuberculosis].
    Kumazawa Y; Mizunoe K
    Nihon Rinsho; 1974 Jul; 32(7):2509-13. PubMed ID: 4215910
    [No Abstract]   [Full Text] [Related]  

  • 13. NIH pre-clinical screening program: overview and current status.
    Izzo A; Brandt L; Lasco T; Kipnis AP; Orme I
    Tuberculosis (Edinb); 2005; 85(1-2):25-8. PubMed ID: 15687024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal application of lentinan enhances bactericidal activity of rat alveolar macrophages against Mycobacterium tuberculosis.
    Markova N; Michailova L; Kussovski V; Jourdanova M; Radoucheva T
    Pharmazie; 2005 Jan; 60(1):42-8. PubMed ID: 15700777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of vaccine research and development: tuberculosis.
    Girard MP; Fruth U; Kieny MP
    Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCV-07 (SciClone Pharmaceuticals/Verta).
    Aspinall RJ; Pockros PJ
    Curr Opin Investig Drugs; 2006 Feb; 7(2):180-5. PubMed ID: 16499289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis.
    Ralph AP; Kelly PM; Anstey NM
    Trends Microbiol; 2008 Jul; 16(7):336-44. PubMed ID: 18513971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUTI: a new chance to shorten the treatment of latent tuberculosis infection.
    Cardona PJ
    Tuberculosis (Edinb); 2006; 86(3-4):273-89. PubMed ID: 16545981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.